Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - BIOLIFE SOLUTIONS INC | ex_176291.htm |
| EX-31.2 - EXHIBIT 31.2 - BIOLIFE SOLUTIONS INC | ex_176290.htm |
| EX-31.1 - EXHIBIT 31.1 - BIOLIFE SOLUTIONS INC | ex_176289.htm |
| EX-23.2 - EXHIBIT 23.2 - BIOLIFE SOLUTIONS INC | ex_186826.htm |
| EX-23.1 - EXHIBIT 23.1 - BIOLIFE SOLUTIONS INC | ex_176288.htm |
| 10-K - FORM 10-K - BIOLIFE SOLUTIONS INC | bioli20191231_10k.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BioLife Solutions, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Roderick de Greef, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: May 15, 2020
|
/s/ Roderick de Greef |
|
|
Roderick de Greef |
|
|
Chief Financial Officer |
|